(PharmaNewsWire.Com, March 01, 2018 ) Latin America Cardiac Marker Testing Market is anticipated to grow at 9.45% CAGR from 2016 to 2021 and it is estimated that the Latin-America market was valued at USD 0.28 billion in 2016 and is expected to reach USD 0.44 billion by 2022.
Cardiac markers are biomarkers used to measure and the evaluate heart function. They are primarily discussed in reference of myocardial infarction, but other conditions can lead to an elevation in cardiac marker level. Most of the early markers identified were enzymes, and as an effect of that, the term "cardiac enzymes" is used every now and then. Be that as it may, not all of the markers are presently used are enzymes.
Factor such as increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth. Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.
The Latin America Cardiac Marker Testing Market Segmentation by Type, Product, Disease, and Testing. On the basis of Type, it is segmented into Troponin I & T, CK-MB, Myoglobin, BNP, and hsCRP. The creatine kinase segment is further segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of this market segment. On the basis of Product, it is segmented into Reagent and Instrument. The instrument segment is furtherer segmented into Chemiluminescence, Immunofluorescence, Immunochromatography, and ELISA. On the basis of Disease, it is segmented into Acute Coronary Syndrome, Myocardial Infarction, and Congestive Heart Failure. ACS is expected to be the fasting growing segment driven. Myocardial infarction is anticipated to be the second fastest growing segment. On the basis of Testing, it is segmented into Lab and POC. The laboratory testing segment is expected to hold the largest share of this market segment, while the point-of-care testing segment is expected to register the highest growth rate in this market segment.
On the basis of geography, the market is analyzed under various regions namely Argentina, Brazil and Mexico. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. Manufacturing these devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality.
The market is dominated by companies like the Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
